Quantcast
 

Kelly v. Wyeth

Kelly v. Wyeth

Opposition to drug company’s federal preemption defense in case involving the drug  metaclopramide, which was prescribed to the plaintiff in generic form to remedy her so-called “delayed gastric emptying.”  When she went off the drug, she experienced severe “akathisia” for over a year – a state of extreme anxiety and restlessness.   Her complaint alleges failure to warn in various respects.  In its motion to dismiss, the defendant argues that the plaintiff’s failure-to-warn claims are preempted because they conflict with the FDA’s approval of the drug’s warning label.  Public Justice and CCL joined the case to assist in briefing and arguing the preemption issue at all stages of the case. Lou Bograd of CCL and Public Justice’s Leslie Brueckner are lead counsel; Jerome F. O’Neill of Burlington, Vermont, Ralph Pittle of Bellevue, Washington, and Hector Pineiro of Worcester, Massachusetts, are plaintiff’s trial counsel.



Skip to content